The sixth most common principal diagnosis, sepsis, also takes the title as the most expensive inpatient diagnosis, racking up about $20 billion in hospitals’ aggregated annual costs. Sepsis isn’t ...

New retrospective study in CHEST found procalcitonin testing at admission reduced the length of stay and total cost of care Each year, over $20 billion dollars is spent on sepsis care, making it the ...

HealthDay News — Hospital adoption of procalcitonin (PCT) testing has had little impact on antibiotic prescribing for chronic obstructive pulmonary disease (COPD) exacerbations, according to a study ...

A dangerous and often deadly condition, sepsis affects more than a million Americans every year and the cases continue to increase. A new study examines whether procalcitonin (PCT) testing helps to ...

Procalcitonin (PCT) is a biomarker widely used to assess the risk of bacterial infection and to aid in antibiotic stewardship in patients with lower respiratory tract infections and sepsis. In this ...

WASHINGTON — The use of a procalcitonin (PCT) test to guide antibiotic therapy in patients with lower respiratory tract infections and sepsis is of no value without education on how to interpret the ...

HENNIGSDORF, Germany--(BUSINESS WIRE)--For healthcare professionals facing the complexity of daily requirements in emergency situations, a new point-of-care test, Samsung IB B·R·A·H·M·S PCT assay, ...

Procalcitonin, or PCT, screening on the first day of a patient intensive care unit’s admission appears to be a promising diagnostic tool for identifying sepsis, according to a new study in CHEST.

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.

GLENVIEW, IL, January 10, 2017 - Each year, over $20 billion dollars is spent on sepsis care, making it the most expensive condition managed in U.S. hospitals. Sepsis does not only carry a heavy ...